CD5 CJC with DAC | 99% purity | Peptide type | Factory direct supply | Customization | 796043-06-6
TDS 8 Inquiries
796043-06-6
Pharmaceutical Grade
99%
Hong Kong
customizable
10vials/box
2027-12-30
Tirzepatide,Retatrutide,Survodutide,GHK-CU,GLOW,KLOW
-
Product Description
-
Seller Information
-
Inquiry History
-
DescriptionResearch & Reference Note
CD5 CJC with DAC | 99% purity | Peptide type | Factory direct supply | Customization | 796043-06-6 is listed on ECHEMI for industrial / laboratory sourcing. This listing is for industrial and laboratory research use. Product information on ECHEMI is provided for sourcing and specification reference. It is not medical advice, a clinical recommendation, or an approved therapy description. Always verify regulatory status, purity, and intended use with the supplier and applicable authorities before purchase or use.
Authoritative sourcesDisclaimer: This listing is for industrial and laboratory research use. Product information on ECHEMI is provided for sourcing and specification reference. It is not medical advice, a clinical recommendation, or an approved therapy description. Always verify regulatory status, purity, and intended use with the supplier and applicable authorities before purchase or use.
Reviewed by ECHEMI Scientific Review - Platform editorial review for research chemicals
Certificates-
TDS
Basic Info-
Product Name:
NA
CAS No.:796043-06-6
Molecular Formula:C21H30N2O6S
Molecular Weight:438.54
Categories:
Characteristics-
Density:
1.373±0.10 g/cm3(Temp: 25 °C; Press: 760 Torr)(predicted)
Boiling Point:605.408±63.00 °C(Press: 760.00 Torr)(predicted)
PKA:14.773±0.10(predicted)
-
-
Seller Information
-
Business Type:
Trader
-
Main Products:
Tirzepatide,Retatrutide,Survodutide,GHK-CU,GLOW,KLOW
-
Location:
Building 1, Floor 2, No. 96 Banhe Road, Huangpu District, Guangzhou City, Room 2164
-
Payment Terms:
TT against copy of documents,D/P,L/C,D/A,O/A,TT against B/L draft before shipment,100% TT in advance
-
Average lead Time:
12
-
Total Annual Revenue:
$1 million-$2.5 million
-
Total Employees:
11-50
-
Year of Establishment:
2026
-
Certifications:
COA,COA,COA,COA,COA,COA,COA,COA,COA
"> -
-
Inquiry History8 Inquiries
Country Product Purchase Quantity Date Posted
United States
Retatrutide 10mg Retatrutide 10mg
10 MT May 16, 2026
United States
Peptide
1 MT Feb 13, 2026
United States
Peptide
100 Jan 28, 2026
Ireland
retatrutide 10mg
10 Mar 27, 2026
Canada
Peptide
10 G Mar 1, 2026
Canada
Peptide
1 MT Feb 24, 2026
United States
Retatrutide 10 mg
10 MG Mar 4, 2026
Hongkong, China
Peptide
10000 MT Jan 6, 2026 Post an enquiry for this product
